US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist
  • 24.9000
  • +1.0500+4.40%
Close Feb 28 16:00 ET
  • 24.9000
  • 0.00000.00%
Post 16:55 ET
272.54MMarket Cap-1.07P/E (TTM)

Cidara Therapeutics Key Stats

Cidara Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 240.000K--
--2024/Q30.000 / 433.330K--
--2024/Q2302.000K / 1.300M--
--2024/Q18.463M / 9.033M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 0.000--
--2024/Q4-- / 240.000K--
--2024/Q30.000 / 433.330K--
--2024/Q2302.000K / 1.300M--
--2024/Q18.463M / 9.033M--

Unlock Free Earnings Estimates

Cidara Therapeutics Earnings Reports

Read more

Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Feb 28, 2025

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data